112
Views
10
CrossRef citations to date
0
Altmetric
Original

METHADONE AND HEROIN PRESCRIPTION: BABIES AND BATH WATER

, M.D.
Pages 523-531 | Published online: 03 Jul 2009
 

Abstract

Criticism of methadone treatment abounds in all countries where this intervention is available. Although such criticism is often justified, it is critical to recognize that methadone is the most effective, safe, and cost-effective intervention available, is supported by innumerable studies, and provides considerable benefit to drug users, their families and communities. The major causes of the pervasive deficiencies of methadone treatment is the severe and consistent under- funding and hostile environment, both inevitable by-products of the global commitment over recent decades to an expensive, ineffective, and often counter-productive drug policy overly reliant on supply reduction. Methadone treatment is often criticized by drug war supporters not because of its limitations, but because its very effectiveness highlights the meagre benefits of supply reduction. The compelling arguments to expand pharmacotherapies for heroin dependence by rigorously evaluating prescription heroin treatment should not be based on the real or perceived deficiencies of methadone treatment. Rather, these arguments should be based on the need to provide evidence-based treatment for drug users which has the capacity, range of options, and quality expected in other health care services. The paramount aim should be to improve the current deplorable rates of death, disease, crime, and severe distress now evident in an increasing number of countries.

Additional information

Notes on contributors

Alex Wodak

Alex Wodak, M.D., is Director of the Alcohol and Drug Service, St. Vincent's Hospital, Sydney, Australia. Major interests include prevention of spread of HIV and hepatitis C among injecting drug users, treatment of drug users in prison, and drug policy. Dr Wodak is the President of the Australian Drug Law Reform Foundation and President of the International Harm Reduction Association. He has worked in a number of developing countries to assist efforts to control HIV infection among injecting drug users.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.